TF and cancer: It is noteworthy that in contrast to FXa inhibitors, specific inhibitors of the extrinsic tenase complex (active factor VII/tissue factor, FVIIa–TF complex) are associated with anti-cancer and anti-metastatic activities (Hembrough et al., 2003; Carneiro-Lobo et al., 2009; Zhao et al., 2009).